Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does it Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?
Elassar, A.; Nulsen, J.; Engmann, L.; Benadiva, C.
Journal of Reproductive Medicine 60(5-6): 199-204
2015
ISSN/ISBN: 0024-7758 PMID: 26126296 Document Number: 637668
Document emailed within 1 workday
Related Documents
Shastri, S.M.; Barbieri, E.; Kligman, I.; Schoyer, K.D.; Davis, O.K.; Rosenwaks, Z. 2011: Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide Fertility and Sterility 95(2): 592-595Kim, C.-H.; You, R.-M.; Kang, H.-J.; Ahn, J.-W.; Jeon, I.; Lee, J.-W.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2011: GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSi Clinical and Experimental Reproductive Medicine 38(4): 228-233
Pereira, N.; Petrini, A.C.; Zhou, Z.N.; Lekovich, J.P.; Kligman, I.; Rosenwaks, Z. 2016: Pretreatment of normal responders in fresh in vitro fertilization cycles: a comparison of transdermal estradiol and oral contraceptive pills Clinical and Experimental Reproductive Medicine 43(4): 228-232
Kim, C.-H.; Jeon, G.-H.; Cheon, Y.-P.; Jeon, I.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2009: Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection Fertility and Sterility 92(5): 1758-1760
Hauzman, E.E.; Zapata, A.; Bermejo, A.; Iglesias, C.; Pellicer, A.; Garcia-Velasco, J.A. 2013: Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial Reproductive Biology and Endocrinology: Rb&e 11: 96
Liu, K.E.; Alhajri, M.; Greenblatt, E. 2011: A randomized controlled trial of NuvaRing versus combined oral contraceptive pills for pretreatment in in vitro fertilization cycles Fertility and Sterility 96(3): 605-608
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567
Morotti, M.; Remorgida, V.; Venturini, P.L.; Ferrero, S. 2014: Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura European Journal of Obstetrics Gynecology and Reproductive Biology 179: 63-68
Pintiaux, A.; Gaspard, U.; Nisolle, M. 2012: Zoely, a combined oral contraceptive, monophasic pill containing estradiol and nomegestrol acetate Revue Medicale de Liege 67(3): 152-156
Keltz, M.D.; Stein, D.E.; Berin, I.; Skorupski, J. 2012: Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization Journal of Reproductive Medicine 57(1-2): 9-12
Kaunitz, A.M.; Burkman, R.T.; Fisher, A.C.; LaGuardia, K.D. 2009: Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial Obstetrics and Gynecology 114(6): 1205-1212
Grzechocińska, B.; Fracki, S.ła.; Marianowski, P.; Dworniak, T.; Bablok, L.; Marianowski, L. 2003: Protocol of GNRH antagonist in poor responders in IVF-ET cycles Ginekologia Polska 74(9): 943-948
Minozzi, M.; Costantino, D.; Guaraldi, C.; Unfer, V. 2011: The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(11): 920-924
Bakas, P.; Hassiakos, D.; Grigoriadis, C.; Vlahos, N.F.; Liapis, A.; Creatsas, G. 2014: Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(11): 825-829
Thomas, R.L.; Halvorson, L.M.; Carr, B.R.; Doody, K.M.; Doody, K.J. 2013: Efficacy of combined contraceptive vaginal ring versus oral contraceptive pills in achieving hypothalamic-pituitary-ovarian axis suppression in egg donor in vitro fertilization cycles Journal of Reproduction and Infertility 14(4): 207-213
Mahendira, D.; Thavaneswaran, A.; Carty, A.; Haroon, N.; Anton, A.; Passalent, L.; Alnaqbi, K.A.; Savage, L.; Aslanyan, E.; Inman, R.D. 2014: Analysis of the effect of the oral contraceptive pill on clinical outcomes in women with ankylosing spondylitis Journal of Rheumatology 41(7): 1344-1348
Sivasubramanian, R.; Chakraborty, A.; Rouzade-Dominguez, M.-L.; Neelakantham, S.; Jakab, A.; Mensinga, T.; Legangneux, E.; Woessner, R.; Ufer, M. 2015: Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women International Journal of Clinical Pharmacology and Therapeutics 53(7): 550-556